Nuno Guimarães
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nuno Guimarães has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Nuno Filipe Azevedo
LEPABE/ALiCE-Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal
14 shared publications - Ceu Figueiredo
I3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
9 shared publications - Jesper Wengel
Biomolecular Nanoscale Engineering Center, Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Odense, Denmark
5 shared publications - Silvia Fontenete
Medical Department BioScience GmbH Madrid Spain
5 shared publications - Pedro Madureira
University of Porto
4 shared publications - Joana Angélica Loureiro
University of Porto Rua Dr. Roberto Frias
3 shared publications
Latest Publications
- Open Access
- 28 May 2026
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 14, 1850483
Liposomes as delivery vectors for nucleic acid mimics into Escherichia coli: effect of composition and functionalization
The growing threat of antimicrobial resistance (AMR) requires the development of novel therapeutic solutions and Nucleic Acid Mimics (NAMs) arepresent a promising alternative. NAMs can hybridize with intracellular bacterial mRNA, working as antisense oligonucleotides (ASOs), being therefore potentially applied as targeted therapeutics (ASObiotics). Because NAMs do not naturally penetrate the bacterial envelope, effective delivery vectors are required. Liposomes represent a promising strategy to overcome this barrier, but their interaction with bacterial envelopes remains poorly understood. Here, we evaluated multiple liposomal formulations as delivery vectors for Cy3-labelled LNA/2′-O-methyl NAMs, targeting the essential acpP bacterial gene. Liposomes were engineered using different pairings of cationic/ionizable and helper lipids, a PEG-conjugated stabilizing lipid, and anti- Escherichia coli ( E. coli ) polyclonal antibodies. A DOTAP/DOPE formulation at 75:25 M ratio achieved over 80% delivery efficiency in E. coli . However, the inclusion of DSPE-methoxy-PEG resulted in reduced efficiency. The conjugation of anti- E. coli polyclonal antibodies significantly enhanced species-specific delivery, reducing labeling efficiency in non-target bacteria by approximately 20%. Higher antibody amounts improved delivery efficiency and specificity. The formulations showed no detectable cytotoxicity in vivo using the Galleria mellonella infection model. These findings demonstrate that antibody-functionalized liposomes provide an effective and selective platform for NAM delivery to bacterial cells.
- 28 May 2026
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 14, 1850483
Open AccessLiposomes as delivery vectors for nucleic acid mimics into Escherichia coli: effect of composition and functionalization
The growing threat of antimicrobial resistance (AMR) requires the development of novel therapeutic solutions and Nucleic Acid Mimics (NAMs) arepresent a promising alternative. NAMs can hybridize with intracellular bacterial mRNA, working as antisense oligonucleotides (ASOs), being therefore potentially applied as targeted therapeutics (ASObiotics). Because NAMs do not naturally penetrate the bacterial envelope, effective delivery vectors are required. Liposomes represent a promising strategy to overcome this barrier, but their interaction with bacterial envelopes remains poorly understood. Here, we evaluated multiple liposomal formulations as delivery vectors for Cy3-labelled LNA/2′-O-methyl NAMs, targeting the essential acpP bacterial gene. Liposomes were engineered using different pairings of cationic/ionizable and helper lipids, a PEG-conjugated stabilizing lipid, and anti- Escherichia coli ( E. coli ) polyclonal antibodies. A DOTAP/DOPE formulation at 75:25 M ratio achieved over 80% delivery efficiency in E. coli . However, the inclusion of DSPE-methoxy-PEG resulted in reduced efficiency. The conjugation of anti- E. coli polyclonal antibodies significantly enhanced species-specific delivery, reducing labeling efficiency in non-target bacteria by approximately 20%. Higher antibody amounts improved delivery efficiency and specificity. The formulations showed no detectable cytotoxicity in vivo using the Galleria mellonella infection model. These findings demonstrate that antibody-functionalized liposomes provide an effective and selective platform for NAM delivery to bacterial cells.
- Open Access
- 1 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (21) , 10666
PLGA Nanoparticles Double-Decorated with a TAT Peptide and Folic Acid to Target Staphylococcus aureus
Treating bacterial infections has become increasingly difficult due to the rise in antibiotic-resistant bacterial strains. Strategies involving the targeted delivery of antibiotics have been proposed to minimize the administered antibiotic doses. This study aims to develop the first double-modified nanovehicle capable of increasing bacterial membranes’ permeability while specifically targeting Staphylococcus aureus, one of the foremost pathogens responsible for global mortality rates. Thus, polymeric NPs composed of poly(lactic-co-glycolic acid) (PLGA) were produced, and their surface was modified with TAT peptide to increase the membranes’ permeability and folic acid (FA) to direct the NPs to S. aureus. The nanosystem showed spherical morphology with sizes of 174 ± 4 nm, a monodisperse population (polydispersity index of 0.08 ± 0.02), and a zeta potential of −2.5 ± 0.1 mV. The NPs remained stable for up to four months during storage. Fluorescence-based flow cytometry analysis proved that the double modification of PLGA NPs increased the interaction of the NPs with S. aureus, with fluorescence increasing from 71 ± 3% to 87 ± 1%. The nanosystem slightly affected the growth curve of S. aureus by extending both the lag time (from 2.5 ± 0.2 to 2.88 ± 0.4 h) and the exponential phase, as evidenced by an increase in the half-maximum growth time (from 3.9 ± 0.2 to 4.4 ± 0.1 h). Furthermore, the nanocarrier showed no toxicity for human dermal fibroblast cells, maintaining a 100% cell viability at the highest concentration tested (100 µM). Therefore, the proposed FA/TAT-functionalized nanocarrier presented promising features to be successfully used as a delivery vehicle of antimicrobials to fight S. aureus.
- 1 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (21) , 10666
Open AccessPLGA Nanoparticles Double-Decorated with a TAT Peptide and Folic Acid to Target Staphylococcus aureus
Treating bacterial infections has become increasingly difficult due to the rise in antibiotic-resistant bacterial strains. Strategies involving the targeted delivery of antibiotics have been proposed to minimize the administered antibiotic doses. This study aims to develop the first double-modified nanovehicle capable of increasing bacterial membranes’ permeability while specifically targeting Staphylococcus aureus, one of the foremost pathogens responsible for global mortality rates. Thus, polymeric NPs composed of poly(lactic-co-glycolic acid) (PLGA) were produced, and their surface was modified with TAT peptide to increase the membranes’ permeability and folic acid (FA) to direct the NPs to S. aureus. The nanosystem showed spherical morphology with sizes of 174 ± 4 nm, a monodisperse population (polydispersity index of 0.08 ± 0.02), and a zeta potential of −2.5 ± 0.1 mV. The NPs remained stable for up to four months during storage. Fluorescence-based flow cytometry analysis proved that the double modification of PLGA NPs increased the interaction of the NPs with S. aureus, with fluorescence increasing from 71 ± 3% to 87 ± 1%. The nanosystem slightly affected the growth curve of S. aureus by extending both the lag time (from 2.5 ± 0.2 to 2.88 ± 0.4 h) and the exponential phase, as evidenced by an increase in the half-maximum growth time (from 3.9 ± 0.2 to 4.4 ± 0.1 h). Furthermore, the nanocarrier showed no toxicity for human dermal fibroblast cells, maintaining a 100% cell viability at the highest concentration tested (100 µM). Therefore, the proposed FA/TAT-functionalized nanocarrier presented promising features to be successfully used as a delivery vehicle of antimicrobials to fight S. aureus.
- 3 June 2024
- Published by Taylor & Francis in Critical Reviews in Biotechnology
- Vol. 45 (1) , 128-147
Oligonucleotide probes for imaging and diagnosis of bacterial infections
The rise of infectious diseases as a public health concern has necessitated the development of rapid and precise diagnostic methods. Imaging techniques like nuclear and optical imaging provide the ability to diagnose infectious diseases within the body, eliminating delays caused by sampling and pre-enrichments of clinical samples and offering spatial information that can aid in a more informed diagnosis. Traditional molecular probes are typically created to image infected tissue without accurately identifying the pathogen. In contrast, oligonucleotides can be tailored to target specific RNA sequences, allowing for the identification of pathogens, and even generating antibiotic susceptibility profiles by focusing on drug resistance genes. Despite the benefits that nucleic acid mimics (NAMs) have provided in terms of stabilizing oligonucleotides, the inadequate delivery of these relatively large molecules into the cytoplasm of bacteria remains a challenge for widespread use of this technology. This review summarizes the key advancements in the field of oligonucleotide probes for in vivo imaging, highlighting the most promising delivery systems described in the literature for developing optical imaging through in vivo hybridization.
- 3 June 2024
- Published by Taylor & Francis in Critical Reviews in Biotechnology
- Vol. 45 (1) , 128-147
Oligonucleotide probes for imaging and diagnosis of bacterial infections
The rise of infectious diseases as a public health concern has necessitated the development of rapid and precise diagnostic methods. Imaging techniques like nuclear and optical imaging provide the ability to diagnose infectious diseases within the body, eliminating delays caused by sampling and pre-enrichments of clinical samples and offering spatial information that can aid in a more informed diagnosis. Traditional molecular probes are typically created to image infected tissue without accurately identifying the pathogen. In contrast, oligonucleotides can be tailored to target specific RNA sequences, allowing for the identification of pathogens, and even generating antibiotic susceptibility profiles by focusing on drug resistance genes. Despite the benefits that nucleic acid mimics (NAMs) have provided in terms of stabilizing oligonucleotides, the inadequate delivery of these relatively large molecules into the cytoplasm of bacteria remains a challenge for widespread use of this technology. This review summarizes the key advancements in the field of oligonucleotide probes for in vivo imaging, highlighting the most promising delivery systems described in the literature for developing optical imaging through in vivo hybridization.
- Open Access
- 20 May 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (10) , 9030
Fighting Methicillin-Resistant Staphylococcus aureus with Targeted Nanoparticles
Antimicrobial resistance (AMR) is considered one of the greatest threats to global health. Methicillin-resistant Staphylococcus aureus (MRSA) remains at the core of this threat, accounting for about 90% of S. aureus infections widespread in the community and hospital settings. In recent years, the use of nanoparticles (NPs) has emerged as a promising strategy to treat MRSA infections. NPs can act directly as antibacterial agents via antibiotic-independent activity and/or serve as drug delivery systems (DDSs), releasing loaded antibiotics. Nonetheless, directing NPs to the infection site is fundamental for effective MRSA treatment so that highly concentrated therapeutic agents are delivered to the infection site while directly reducing the toxicity to healthy human cells. This leads to decreased AMR emergence and less disturbance of the individual’s healthy microbiota. Hence, this review compiles and discusses the scientific evidence related to targeted NPs developed for MRSA treatment.
- 20 May 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (10) , 9030
Open AccessFighting Methicillin-Resistant Staphylococcus aureus with Targeted Nanoparticles
Antimicrobial resistance (AMR) is considered one of the greatest threats to global health. Methicillin-resistant Staphylococcus aureus (MRSA) remains at the core of this threat, accounting for about 90% of S. aureus infections widespread in the community and hospital settings. In recent years, the use of nanoparticles (NPs) has emerged as a promising strategy to treat MRSA infections. NPs can act directly as antibacterial agents via antibiotic-independent activity and/or serve as drug delivery systems (DDSs), releasing loaded antibiotics. Nonetheless, directing NPs to the infection site is fundamental for effective MRSA treatment so that highly concentrated therapeutic agents are delivered to the infection site while directly reducing the toxicity to healthy human cells. This leads to decreased AMR emergence and less disturbance of the individual’s healthy microbiota. Hence, this review compiles and discusses the scientific evidence related to targeted NPs developed for MRSA treatment.
- Open Access
- 14 February 2023
- Published by Elsevier in Journal of Controlled Release
- Vol. 355, 489-500
Engineered liposomes to deliver nucleic acid mimics in Escherichia coli
- 14 February 2023
- Published by Elsevier in Journal of Controlled Release
- Vol. 355, 489-500
Open AccessEngineered liposomes to deliver nucleic acid mimics in Escherichia coli
- Open Access
- 23 June 2022
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 8 (7) , 1218-1230
Liposome Delivery of Nucleic Acids in Bacteria: Toward In Vivo Labeling of Human Microbiota
Development of specific probes to study the in vivo spatial distribution of microorganisms is essential to understand the ecology of human microbiota. Herein, we assess the possibility of using liposomes loaded with fluorescently labeled nucleic acid mimics (LipoNAMs) to image Gram-negative and Gram-positive bacteria. We proved that liposome fusion efficiencies were similar in both Gram-negative and Gram-positive bacteria but that the efficiency was highly dependent on the lipid concentration. Notably, LipoNAMs were significantly more effective for the internalization of oligonucleotides in bacteria than the fixation/permeabilization methods commonly used in vitro. Furthermore, a structural and morphological assessment of the changes on bacteria allowed us to observe that liposomes increased the permeability of the cell envelope especially in Gram-negative bacteria. Considering the delivery efficiency and permeabilization effect, lipid concentrations of approximately 5 mM should be selected to maximize the detection of bacteria without compromising the bacterial cellular structure.
- 23 June 2022
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 8 (7) , 1218-1230
Open AccessLiposome Delivery of Nucleic Acids in Bacteria: Toward In Vivo Labeling of Human Microbiota
Development of specific probes to study the in vivo spatial distribution of microorganisms is essential to understand the ecology of human microbiota. Herein, we assess the possibility of using liposomes loaded with fluorescently labeled nucleic acid mimics (LipoNAMs) to image Gram-negative and Gram-positive bacteria. We proved that liposome fusion efficiencies were similar in both Gram-negative and Gram-positive bacteria but that the efficiency was highly dependent on the lipid concentration. Notably, LipoNAMs were significantly more effective for the internalization of oligonucleotides in bacteria than the fixation/permeabilization methods commonly used in vitro. Furthermore, a structural and morphological assessment of the changes on bacteria allowed us to observe that liposomes increased the permeability of the cell envelope especially in Gram-negative bacteria. Considering the delivery efficiency and permeabilization effect, lipid concentrations of approximately 5 mM should be selected to maximize the detection of bacteria without compromising the bacterial cellular structure.
- Open Access
- 29 June 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (7) , 989
Lipoplexes to Deliver Oligonucleotides in Gram-Positive and Gram-Negative Bacteria: Towards Treatment of Blood Infections
Bacterial resistance to antibiotics threatens the ability to treat life-threatening bloodstream infections. Oligonucleotides (ONs) composed of nucleic acid mimics (NAMs) able to inhibit essential genes can become an alternative to traditional antibiotics, as long as they are safely transported in human serum upon intravenous administration and they are carried across the multilayered bacterial envelopes, impermeable to ONs. In this study, fusogenic liposomes were considered to transport the ONs and promote their internalization in clinically relevant bacteria. Locked nucleic acids and 2′-OMethyl RNA were evaluated as model NAMs and formulated into DOTAP–DOPE liposomes followed by post-PEGylation. Our data showed a complexation stability between the post-PEGylated liposomes and the ONs of over 82%, during 24 h in native human serum, as determined by fluorescence correlation spectroscopy. Quantification by a lipid-mixing assay showed that liposomes, with and without post-PEGylation, fused with all bacteria tested. Such fusion promoted the delivery of a fraction of the ONs into the bacterial cytosol, as observed by fluorescence in situ hybridization and bacterial fractionation. In short, we demonstrated for the first time that liposomes can safely transport ONs in human serum and intracellularly deliver them in both Gram-negative and -positive bacteria, which holds promise towards the treatment of bloodstream infections.
- 29 June 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (7) , 989
Open AccessLipoplexes to Deliver Oligonucleotides in Gram-Positive and Gram-Negative Bacteria: Towards Treatment of Blood Infections
Bacterial resistance to antibiotics threatens the ability to treat life-threatening bloodstream infections. Oligonucleotides (ONs) composed of nucleic acid mimics (NAMs) able to inhibit essential genes can become an alternative to traditional antibiotics, as long as they are safely transported in human serum upon intravenous administration and they are carried across the multilayered bacterial envelopes, impermeable to ONs. In this study, fusogenic liposomes were considered to transport the ONs and promote their internalization in clinically relevant bacteria. Locked nucleic acids and 2′-OMethyl RNA were evaluated as model NAMs and formulated into DOTAP–DOPE liposomes followed by post-PEGylation. Our data showed a complexation stability between the post-PEGylated liposomes and the ONs of over 82%, during 24 h in native human serum, as determined by fluorescence correlation spectroscopy. Quantification by a lipid-mixing assay showed that liposomes, with and without post-PEGylation, fused with all bacteria tested. Such fusion promoted the delivery of a fraction of the ONs into the bacterial cytosol, as observed by fluorescence in situ hybridization and bacterial fractionation. In short, we demonstrated for the first time that liposomes can safely transport ONs in human serum and intracellularly deliver them in both Gram-negative and -positive bacteria, which holds promise towards the treatment of bloodstream infections.
- 13 February 2021
- Published by Springer Nature
- Vol. 2246, 17-33
FISH Variants
FISH has gained an irreplaceable place in microbiology because of its ability to detect and locate a microorganism, or a group of organisms, within complex samples. However, FISH role has evolved drastically in the last few decades and its value has been boosted by several advances in signal intensity, imaging acquisitions, automation, method robustness, and, thus, versatility. This has resulted in a range of FISH variants that gave researchers the ability to access a variety of other valuable information such as complex population composition, metabolic activity, gene detection/quantification, or subcellular location of genetic elements. In this chapter, we will review the more relevant FISH variants, their intended use, and how they address particular challenges of classical FISH.
- 13 February 2021
- Published by Springer Nature
- Vol. 2246, 17-33
FISH Variants
FISH has gained an irreplaceable place in microbiology because of its ability to detect and locate a microorganism, or a group of organisms, within complex samples. However, FISH role has evolved drastically in the last few decades and its value has been boosted by several advances in signal intensity, imaging acquisitions, automation, method robustness, and, thus, versatility. This has resulted in a range of FISH variants that gave researchers the ability to access a variety of other valuable information such as complex population composition, metabolic activity, gene detection/quantification, or subcellular location of genetic elements. In this chapter, we will review the more relevant FISH variants, their intended use, and how they address particular challenges of classical FISH.